Radiolabelling of human recombinant IL-2 with short-lived positron-emitting radionuclides such as fluorine-18 (18F−) have already been shown to provide a tool for non-invasive imaging of activated tumour infiltrating lymphocytes (TILs) in cancer. This evidence concerns the gene IL2 and cancer.